Literature DB >> 21128778

Utilization of fluorescence in situ hybridization in the diagnosis of 230 mesenchymal neoplasms: an institutional experience.

Munir R Tanas1, Brian P Rubin, Raymond R Tubbs, Steven D Billings, Erinn Downs-Kelly, John R Goldblum.   

Abstract

CONTEXT: Mesenchymal neoplasms harbor characteristic translocations and amplification of gene regions amenable to evaluation by fluorescence in situ hybridization (FISH).
OBJECTIVE: To determine the utility of FISH in the diagnosis of mesenchymal neoplasms.
DESIGN: Two hundred thirty soft tissue cases analyzed by FISH were reviewed retrospectively.
RESULTS: Morphologic patterns where FISH was used included high-grade round cell sarcomas (n  =  67), nonmyogenic spindle cell sarcomas (n  =  40), low-grade myxoid neoplasms (n  =  34), adipocytic neoplasms (n  =  20), and melanocytic neoplasms (n  =  19). Fifty cases did not fit into the previously mentioned categories. SYT FISH (96% of monophasic synovial sarcomas were positive; 0% of malignant peripheral nerve sheath tumor were positive) and DDIT3 FISH (100% of myxoid/round cell liposarcomas; no other neoplasm positive) were very sensitive and specific. EWSR1 FISH was very sensitive and specific in the differential diagnosis of melanocytic neoplasms (88% of clear cell sarcomas were positive; all melanomas were negative). EWSR1 FISH was sensitive among high-grade round cell sarcomas (positive in 100% of desmoplastic small round cell tumors and 96% of Ewing sarcoma/primitive neuroectodermal tumors) but not specific because clear cell sarcoma, extraskeletal myxoid chondrosarcoma, and a subset of round cell liposarcomas also harbor rearrangements of EWSR1. FUS FISH was very sensitive in detecting low-grade fibromyxoid sarcomas (91% positive) but not specific because most myxoid/round cell liposarcomas also contain rearrangements of FUS. All atypical lipomatous tumors were positive for amplification of MDM2, whereas all lipomas were negative. FOXO1A FISH was positive in ∼70% of cases of alveolar rhabdomyosarcoma.
CONCLUSION: FISH is a useful adjunct in the diagnosis of mesenchymal neoplasms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21128778     DOI: 10.5858/2009-0571-OAR.1

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  10 in total

1.  Malignant gastrointestinal neuroectodermal tumor: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of 16 cases with a reappraisal of clear cell sarcoma-like tumors of the gastrointestinal tract.

Authors:  David L Stockman; Markku Miettinen; Saul Suster; Dominic Spagnolo; Hugo Dominguez-Malagon; Jason L Hornick; Volkan Adsay; Pauline M Chou; Benhur Amanuel; Peter Vantuinen; Eduardo V Zambrano
Journal:  Am J Surg Pathol       Date:  2012-06       Impact factor: 6.394

2.  A newly characterized human well-differentiated liposarcoma cell line contains amplifications of the 12q12-21 and 10p11-14 regions.

Authors:  Florence Pedeutour; Georges Maire; Anne Pierron; David M Thomas; Dale W Garsed; Laurence Bianchini; Valérie Duranton-Tanneur; Annabelle Cortes-Maurel; Antoine Italiano; Jeremy A Squire; Jean-Michel Coindre
Journal:  Virchows Arch       Date:  2012-06-08       Impact factor: 4.064

3.  The comparative utility of fluorescence in situ hybridization and reverse transcription-polymerase chain reaction in the diagnosis of alveolar rhabdomyosarcoma.

Authors:  Khin Thway; Jayson Wang; Dorte Wren; Melissa Dainton; David Gonzalez; John Swansbury; Cyril Fisher
Journal:  Virchows Arch       Date:  2015-04-26       Impact factor: 4.064

Review 4.  Nonproliferative and Proliferative Lesions of the Rat and Mouse Skeletal Tissues (Bones, Joints, and Teeth).

Authors:  Stacey Fossey; John Vahle; Philip Long; Scott Schelling; Heinrich Ernst; Rogely Waite Boyce; Jacquelin Jolette; Brad Bolon; Alison Bendele; Matthias Rinke; Laura Healy; Wanda High; Daniel Robert Roth; Michael Boyle; Joel Leininger
Journal:  J Toxicol Pathol       Date:  2016-07-29       Impact factor: 1.628

5.  Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Stomach.

Authors:  Safi Khuri; Hayim Gilshtein; Sa'd Sayidaa; Bishara Bishara; Yoram Kluger
Journal:  Case Rep Oncol       Date:  2016-11-01

6.  Extraskeletal Ewing's sarcoma/peripheral primitive neuroectodermal tumor of the small bowel presenting with gastrointestinal perforation.

Authors:  Vipul D Yagnik; Sushil Dawka
Journal:  Clin Exp Gastroenterol       Date:  2019-06-25

7.  Automated 3D scoring of fluorescence in situ hybridization (FISH) using a confocal whole slide imaging scanner.

Authors:  Ziv Frankenstein; Naohiro Uraoka; Umut Aypar; Ruth Aryeequaye; Mamta Rao; Meera Hameed; Yanming Zhang; Yukako Yagi
Journal:  Appl Microsc       Date:  2021-04-09

8.  Ewing's Sarcoma of the Stomach; Rare Case of Ewing's Sarcoma and Suggestion of New Treatment Strategy.

Authors:  Hyo-Sin Kim; Sungsoo Kim; Young-Don Min; Keun-Hong Kee; Ran Hong
Journal:  J Gastric Cancer       Date:  2012-12-31       Impact factor: 3.720

9.  Cytogenetics and molecular genetics of myxoid soft-tissue sarcomas.

Authors:  Jun Nishio; Hiroshi Iwasaki; Kazuki Nabeshima; Masatoshi Naito
Journal:  Genet Res Int       Date:  2011-07-28

Review 10.  Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancers.

Authors:  Nil A Schubert; Caitlin D Lowery; Guillaume Bergthold; Jan Koster; Thomas F Eleveld; Ana Rodríguez; David T W Jones; Gilles Vassal; Louis F Stancato; Stefan M Pfister; Hubert N Caron; Jan J Molenaar
Journal:  Eur J Cancer       Date:  2020-03-27       Impact factor: 9.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.